Will Saunders Bring Transformation To Forest?
This article was originally published in The Pink Sheet Daily
Executive Summary
The specialty pharma long has been scrutinized for its decisions regarding the patent cliff and business development. Now, a new CEO will have the chance to keep the company on its current course or mirror the transformations he’s put in motion at other companies.